Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
The prevalence of diabetes around the world has reached epidemic proportions and is projected to increase to 642 million people by 2040. Diabetes is already the leading cause of end-stage kidney disease (ESKD) in most developed countries, and the growth in the number of people with ESKD around the w...
Gespeichert in:
| Veröffentlicht in: | Kidney international 2016-12, Vol.90 (6), p.1175-1183 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1183 |
|---|---|
| container_issue | 6 |
| container_start_page | 1175 |
| container_title | Kidney international |
| container_volume | 90 |
| creator | Perkovic, Vlado Agarwal, Rajiv Fioretto, Paola Hemmelgarn, Brenda R. Levin, Adeera Thomas, Merlin C. Wanner, Christoph Kasiske, Bertram L. Wheeler, David C. Groop, Per-Henrik Bakris, George L. Cooper, Mark E. Chae, Dong-Wan Davidson, Michael H. de Boer, Ian H. de Zeeuw, Dick Fornoni, Alessia Gnudi, Luigi Herzog, Charles A. Hung, Adriana M. Jafar, Tazeen Hasan Jardine, Meg Jha, Vivekanand Ji, Linong Kahn, Steven E. Langham, Robyn G. Lerma, Edgar V. Ma, Ronald C.W. Makino, Hirofumi Marre, Michel Mauer, Michael Metsärinne, Kaj Nelson, Robert G. Pecoits-Filho, Roberto Pollock, Carol A. Rajapurkar, Mohan Rossing, Peter Rychlík, Ivan Sharma, Kumar Stanton, Robert C. Tesař, Vladimír Tikkanen, Ilkka Tomson, Charlie R.V. Toto, Robert D. Tsukamoto, Yusuke Tuttle, Katherine R. Wada, Takashi Williams, Winfred W. Zhang, Hong Zoungas, Sophia |
| description | The prevalence of diabetes around the world has reached epidemic proportions and is projected to increase to 642 million people by 2040. Diabetes is already the leading cause of end-stage kidney disease (ESKD) in most developed countries, and the growth in the number of people with ESKD around the world parallels the increase in diabetes. The presence of kidney disease is associated with a markedly elevated risk of cardiovascular disease and death in people with diabetes. Several new therapies and novel investigational agents targeting chronic kidney disease patients with diabetes are now under development. This conference was convened to assess our current state of knowledge regarding optimal glycemic control, current antidiabetic agents and their safety, and new therapies being developed to improve kidney function and cardiovascular outcomes for this vulnerable population. |
| doi_str_mv | 10.1016/j.kint.2016.09.010 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1844025881</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0085253816305154</els_id><sourcerecordid>1844025881</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-85ad70464ec22a4bfccb945fe5868d880592cbf42122a84c0603ce0e426800673</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhiMEotvCC3BAPpZDwtixs07FBe3CstqivcDZcpxJ8ZLYi50U9dZn6BkknoVH6ZPg1RaOnGZG_uYfz_xZ9oJCQYFWr3fFV-vGgqW8gLoACo-yGRWszOlciMfZDECKnIlSnmSnMe4g1XUJT7MTNpeSl5TNsruP2ukrHNCNxHdkr0eb0ki-2_ELaa1ucMRItGvJYrO8-P3LeGf6KVrvIumCH4gm97c_NrZ1eEOWNqKOeEHWwz74a-uuyKr3je7JdhqNHzDe3_4k55vlerV9RRbejYnCEG0akaoOAzqDz7Inne4jPn-IZ9nn9-8-LT7kl9vVevH2MjccYMyl0O0ceMXRMKZ50xnT1Fx0KGQlWylB1Mw0HWc0PUtuoILSICBnlQSo5uVZdn7UTX_9NmEc1WCjwb7XDv0UFZWcAxNS0oSyI2qCjzFgp_bBDjrcKArq4IXaqYMX6uCFglolL1LTywf9qRmw_dfy9_gJeHMEMG15bTGoaOzhAq0NaEbVevs__T8ddJ35</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1844025881</pqid></control><display><type>article</type><title>Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Perkovic, Vlado ; Agarwal, Rajiv ; Fioretto, Paola ; Hemmelgarn, Brenda R. ; Levin, Adeera ; Thomas, Merlin C. ; Wanner, Christoph ; Kasiske, Bertram L. ; Wheeler, David C. ; Groop, Per-Henrik ; Bakris, George L. ; Cooper, Mark E. ; Chae, Dong-Wan ; Davidson, Michael H. ; de Boer, Ian H. ; de Zeeuw, Dick ; Fornoni, Alessia ; Gnudi, Luigi ; Herzog, Charles A. ; Hung, Adriana M. ; Jafar, Tazeen Hasan ; Jardine, Meg ; Jha, Vivekanand ; Ji, Linong ; Kahn, Steven E. ; Langham, Robyn G. ; Lerma, Edgar V. ; Ma, Ronald C.W. ; Makino, Hirofumi ; Marre, Michel ; Mauer, Michael ; Metsärinne, Kaj ; Nelson, Robert G. ; Pecoits-Filho, Roberto ; Pollock, Carol A. ; Rajapurkar, Mohan ; Rossing, Peter ; Rychlík, Ivan ; Sharma, Kumar ; Stanton, Robert C. ; Tesař, Vladimír ; Tikkanen, Ilkka ; Tomson, Charlie R.V. ; Toto, Robert D. ; Tsukamoto, Yusuke ; Tuttle, Katherine R. ; Wada, Takashi ; Williams, Winfred W. ; Zhang, Hong ; Zoungas, Sophia</creator><creatorcontrib>Perkovic, Vlado ; Agarwal, Rajiv ; Fioretto, Paola ; Hemmelgarn, Brenda R. ; Levin, Adeera ; Thomas, Merlin C. ; Wanner, Christoph ; Kasiske, Bertram L. ; Wheeler, David C. ; Groop, Per-Henrik ; Bakris, George L. ; Cooper, Mark E. ; Chae, Dong-Wan ; Davidson, Michael H. ; de Boer, Ian H. ; de Zeeuw, Dick ; Fornoni, Alessia ; Gnudi, Luigi ; Herzog, Charles A. ; Hung, Adriana M. ; Jafar, Tazeen Hasan ; Jardine, Meg ; Jha, Vivekanand ; Ji, Linong ; Kahn, Steven E. ; Langham, Robyn G. ; Lerma, Edgar V. ; Ma, Ronald C.W. ; Makino, Hirofumi ; Marre, Michel ; Mauer, Michael ; Metsärinne, Kaj ; Nelson, Robert G. ; Pecoits-Filho, Roberto ; Pollock, Carol A. ; Rajapurkar, Mohan ; Rossing, Peter ; Rychlík, Ivan ; Sharma, Kumar ; Stanton, Robert C. ; Tesař, Vladimír ; Tikkanen, Ilkka ; Tomson, Charlie R.V. ; Toto, Robert D. ; Tsukamoto, Yusuke ; Tuttle, Katherine R. ; Wada, Takashi ; Williams, Winfred W. ; Zhang, Hong ; Zoungas, Sophia ; Conference Participants</creatorcontrib><description>The prevalence of diabetes around the world has reached epidemic proportions and is projected to increase to 642 million people by 2040. Diabetes is already the leading cause of end-stage kidney disease (ESKD) in most developed countries, and the growth in the number of people with ESKD around the world parallels the increase in diabetes. The presence of kidney disease is associated with a markedly elevated risk of cardiovascular disease and death in people with diabetes. Several new therapies and novel investigational agents targeting chronic kidney disease patients with diabetes are now under development. This conference was convened to assess our current state of knowledge regarding optimal glycemic control, current antidiabetic agents and their safety, and new therapies being developed to improve kidney function and cardiovascular outcomes for this vulnerable population.</description><identifier>ISSN: 0085-2538</identifier><identifier>EISSN: 1523-1755</identifier><identifier>DOI: 10.1016/j.kint.2016.09.010</identifier><identifier>PMID: 27884312</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>antidiabetic agents ; cardiovascular disease ; chronic kidney disease ; diabetes ; Diabetic Nephropathies - therapy ; glycemic control ; Humans ; Renal Insufficiency, Chronic - therapy ; renoprotection</subject><ispartof>Kidney international, 2016-12, Vol.90 (6), p.1175-1183</ispartof><rights>2016 International Society of Nephrology</rights><rights>Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-85ad70464ec22a4bfccb945fe5868d880592cbf42122a84c0603ce0e426800673</citedby><cites>FETCH-LOGICAL-c400t-85ad70464ec22a4bfccb945fe5868d880592cbf42122a84c0603ce0e426800673</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,23910,23911,25119,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27884312$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Perkovic, Vlado</creatorcontrib><creatorcontrib>Agarwal, Rajiv</creatorcontrib><creatorcontrib>Fioretto, Paola</creatorcontrib><creatorcontrib>Hemmelgarn, Brenda R.</creatorcontrib><creatorcontrib>Levin, Adeera</creatorcontrib><creatorcontrib>Thomas, Merlin C.</creatorcontrib><creatorcontrib>Wanner, Christoph</creatorcontrib><creatorcontrib>Kasiske, Bertram L.</creatorcontrib><creatorcontrib>Wheeler, David C.</creatorcontrib><creatorcontrib>Groop, Per-Henrik</creatorcontrib><creatorcontrib>Bakris, George L.</creatorcontrib><creatorcontrib>Cooper, Mark E.</creatorcontrib><creatorcontrib>Chae, Dong-Wan</creatorcontrib><creatorcontrib>Davidson, Michael H.</creatorcontrib><creatorcontrib>de Boer, Ian H.</creatorcontrib><creatorcontrib>de Zeeuw, Dick</creatorcontrib><creatorcontrib>Fornoni, Alessia</creatorcontrib><creatorcontrib>Gnudi, Luigi</creatorcontrib><creatorcontrib>Herzog, Charles A.</creatorcontrib><creatorcontrib>Hung, Adriana M.</creatorcontrib><creatorcontrib>Jafar, Tazeen Hasan</creatorcontrib><creatorcontrib>Jardine, Meg</creatorcontrib><creatorcontrib>Jha, Vivekanand</creatorcontrib><creatorcontrib>Ji, Linong</creatorcontrib><creatorcontrib>Kahn, Steven E.</creatorcontrib><creatorcontrib>Langham, Robyn G.</creatorcontrib><creatorcontrib>Lerma, Edgar V.</creatorcontrib><creatorcontrib>Ma, Ronald C.W.</creatorcontrib><creatorcontrib>Makino, Hirofumi</creatorcontrib><creatorcontrib>Marre, Michel</creatorcontrib><creatorcontrib>Mauer, Michael</creatorcontrib><creatorcontrib>Metsärinne, Kaj</creatorcontrib><creatorcontrib>Nelson, Robert G.</creatorcontrib><creatorcontrib>Pecoits-Filho, Roberto</creatorcontrib><creatorcontrib>Pollock, Carol A.</creatorcontrib><creatorcontrib>Rajapurkar, Mohan</creatorcontrib><creatorcontrib>Rossing, Peter</creatorcontrib><creatorcontrib>Rychlík, Ivan</creatorcontrib><creatorcontrib>Sharma, Kumar</creatorcontrib><creatorcontrib>Stanton, Robert C.</creatorcontrib><creatorcontrib>Tesař, Vladimír</creatorcontrib><creatorcontrib>Tikkanen, Ilkka</creatorcontrib><creatorcontrib>Tomson, Charlie R.V.</creatorcontrib><creatorcontrib>Toto, Robert D.</creatorcontrib><creatorcontrib>Tsukamoto, Yusuke</creatorcontrib><creatorcontrib>Tuttle, Katherine R.</creatorcontrib><creatorcontrib>Wada, Takashi</creatorcontrib><creatorcontrib>Williams, Winfred W.</creatorcontrib><creatorcontrib>Zhang, Hong</creatorcontrib><creatorcontrib>Zoungas, Sophia</creatorcontrib><creatorcontrib>Conference Participants</creatorcontrib><title>Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference</title><title>Kidney international</title><addtitle>Kidney Int</addtitle><description>The prevalence of diabetes around the world has reached epidemic proportions and is projected to increase to 642 million people by 2040. Diabetes is already the leading cause of end-stage kidney disease (ESKD) in most developed countries, and the growth in the number of people with ESKD around the world parallels the increase in diabetes. The presence of kidney disease is associated with a markedly elevated risk of cardiovascular disease and death in people with diabetes. Several new therapies and novel investigational agents targeting chronic kidney disease patients with diabetes are now under development. This conference was convened to assess our current state of knowledge regarding optimal glycemic control, current antidiabetic agents and their safety, and new therapies being developed to improve kidney function and cardiovascular outcomes for this vulnerable population.</description><subject>antidiabetic agents</subject><subject>cardiovascular disease</subject><subject>chronic kidney disease</subject><subject>diabetes</subject><subject>Diabetic Nephropathies - therapy</subject><subject>glycemic control</subject><subject>Humans</subject><subject>Renal Insufficiency, Chronic - therapy</subject><subject>renoprotection</subject><issn>0085-2538</issn><issn>1523-1755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFu1DAQhiMEotvCC3BAPpZDwtixs07FBe3CstqivcDZcpxJ8ZLYi50U9dZn6BkknoVH6ZPg1RaOnGZG_uYfz_xZ9oJCQYFWr3fFV-vGgqW8gLoACo-yGRWszOlciMfZDECKnIlSnmSnMe4g1XUJT7MTNpeSl5TNsruP2ukrHNCNxHdkr0eb0ki-2_ELaa1ucMRItGvJYrO8-P3LeGf6KVrvIumCH4gm97c_NrZ1eEOWNqKOeEHWwz74a-uuyKr3je7JdhqNHzDe3_4k55vlerV9RRbejYnCEG0akaoOAzqDz7Inne4jPn-IZ9nn9-8-LT7kl9vVevH2MjccYMyl0O0ceMXRMKZ50xnT1Fx0KGQlWylB1Mw0HWc0PUtuoILSICBnlQSo5uVZdn7UTX_9NmEc1WCjwb7XDv0UFZWcAxNS0oSyI2qCjzFgp_bBDjrcKArq4IXaqYMX6uCFglolL1LTywf9qRmw_dfy9_gJeHMEMG15bTGoaOzhAq0NaEbVevs__T8ddJ35</recordid><startdate>201612</startdate><enddate>201612</enddate><creator>Perkovic, Vlado</creator><creator>Agarwal, Rajiv</creator><creator>Fioretto, Paola</creator><creator>Hemmelgarn, Brenda R.</creator><creator>Levin, Adeera</creator><creator>Thomas, Merlin C.</creator><creator>Wanner, Christoph</creator><creator>Kasiske, Bertram L.</creator><creator>Wheeler, David C.</creator><creator>Groop, Per-Henrik</creator><creator>Bakris, George L.</creator><creator>Cooper, Mark E.</creator><creator>Chae, Dong-Wan</creator><creator>Davidson, Michael H.</creator><creator>de Boer, Ian H.</creator><creator>de Zeeuw, Dick</creator><creator>Fornoni, Alessia</creator><creator>Gnudi, Luigi</creator><creator>Herzog, Charles A.</creator><creator>Hung, Adriana M.</creator><creator>Jafar, Tazeen Hasan</creator><creator>Jardine, Meg</creator><creator>Jha, Vivekanand</creator><creator>Ji, Linong</creator><creator>Kahn, Steven E.</creator><creator>Langham, Robyn G.</creator><creator>Lerma, Edgar V.</creator><creator>Ma, Ronald C.W.</creator><creator>Makino, Hirofumi</creator><creator>Marre, Michel</creator><creator>Mauer, Michael</creator><creator>Metsärinne, Kaj</creator><creator>Nelson, Robert G.</creator><creator>Pecoits-Filho, Roberto</creator><creator>Pollock, Carol A.</creator><creator>Rajapurkar, Mohan</creator><creator>Rossing, Peter</creator><creator>Rychlík, Ivan</creator><creator>Sharma, Kumar</creator><creator>Stanton, Robert C.</creator><creator>Tesař, Vladimír</creator><creator>Tikkanen, Ilkka</creator><creator>Tomson, Charlie R.V.</creator><creator>Toto, Robert D.</creator><creator>Tsukamoto, Yusuke</creator><creator>Tuttle, Katherine R.</creator><creator>Wada, Takashi</creator><creator>Williams, Winfred W.</creator><creator>Zhang, Hong</creator><creator>Zoungas, Sophia</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201612</creationdate><title>Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference</title><author>Perkovic, Vlado ; Agarwal, Rajiv ; Fioretto, Paola ; Hemmelgarn, Brenda R. ; Levin, Adeera ; Thomas, Merlin C. ; Wanner, Christoph ; Kasiske, Bertram L. ; Wheeler, David C. ; Groop, Per-Henrik ; Bakris, George L. ; Cooper, Mark E. ; Chae, Dong-Wan ; Davidson, Michael H. ; de Boer, Ian H. ; de Zeeuw, Dick ; Fornoni, Alessia ; Gnudi, Luigi ; Herzog, Charles A. ; Hung, Adriana M. ; Jafar, Tazeen Hasan ; Jardine, Meg ; Jha, Vivekanand ; Ji, Linong ; Kahn, Steven E. ; Langham, Robyn G. ; Lerma, Edgar V. ; Ma, Ronald C.W. ; Makino, Hirofumi ; Marre, Michel ; Mauer, Michael ; Metsärinne, Kaj ; Nelson, Robert G. ; Pecoits-Filho, Roberto ; Pollock, Carol A. ; Rajapurkar, Mohan ; Rossing, Peter ; Rychlík, Ivan ; Sharma, Kumar ; Stanton, Robert C. ; Tesař, Vladimír ; Tikkanen, Ilkka ; Tomson, Charlie R.V. ; Toto, Robert D. ; Tsukamoto, Yusuke ; Tuttle, Katherine R. ; Wada, Takashi ; Williams, Winfred W. ; Zhang, Hong ; Zoungas, Sophia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-85ad70464ec22a4bfccb945fe5868d880592cbf42122a84c0603ce0e426800673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>antidiabetic agents</topic><topic>cardiovascular disease</topic><topic>chronic kidney disease</topic><topic>diabetes</topic><topic>Diabetic Nephropathies - therapy</topic><topic>glycemic control</topic><topic>Humans</topic><topic>Renal Insufficiency, Chronic - therapy</topic><topic>renoprotection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Perkovic, Vlado</creatorcontrib><creatorcontrib>Agarwal, Rajiv</creatorcontrib><creatorcontrib>Fioretto, Paola</creatorcontrib><creatorcontrib>Hemmelgarn, Brenda R.</creatorcontrib><creatorcontrib>Levin, Adeera</creatorcontrib><creatorcontrib>Thomas, Merlin C.</creatorcontrib><creatorcontrib>Wanner, Christoph</creatorcontrib><creatorcontrib>Kasiske, Bertram L.</creatorcontrib><creatorcontrib>Wheeler, David C.</creatorcontrib><creatorcontrib>Groop, Per-Henrik</creatorcontrib><creatorcontrib>Bakris, George L.</creatorcontrib><creatorcontrib>Cooper, Mark E.</creatorcontrib><creatorcontrib>Chae, Dong-Wan</creatorcontrib><creatorcontrib>Davidson, Michael H.</creatorcontrib><creatorcontrib>de Boer, Ian H.</creatorcontrib><creatorcontrib>de Zeeuw, Dick</creatorcontrib><creatorcontrib>Fornoni, Alessia</creatorcontrib><creatorcontrib>Gnudi, Luigi</creatorcontrib><creatorcontrib>Herzog, Charles A.</creatorcontrib><creatorcontrib>Hung, Adriana M.</creatorcontrib><creatorcontrib>Jafar, Tazeen Hasan</creatorcontrib><creatorcontrib>Jardine, Meg</creatorcontrib><creatorcontrib>Jha, Vivekanand</creatorcontrib><creatorcontrib>Ji, Linong</creatorcontrib><creatorcontrib>Kahn, Steven E.</creatorcontrib><creatorcontrib>Langham, Robyn G.</creatorcontrib><creatorcontrib>Lerma, Edgar V.</creatorcontrib><creatorcontrib>Ma, Ronald C.W.</creatorcontrib><creatorcontrib>Makino, Hirofumi</creatorcontrib><creatorcontrib>Marre, Michel</creatorcontrib><creatorcontrib>Mauer, Michael</creatorcontrib><creatorcontrib>Metsärinne, Kaj</creatorcontrib><creatorcontrib>Nelson, Robert G.</creatorcontrib><creatorcontrib>Pecoits-Filho, Roberto</creatorcontrib><creatorcontrib>Pollock, Carol A.</creatorcontrib><creatorcontrib>Rajapurkar, Mohan</creatorcontrib><creatorcontrib>Rossing, Peter</creatorcontrib><creatorcontrib>Rychlík, Ivan</creatorcontrib><creatorcontrib>Sharma, Kumar</creatorcontrib><creatorcontrib>Stanton, Robert C.</creatorcontrib><creatorcontrib>Tesař, Vladimír</creatorcontrib><creatorcontrib>Tikkanen, Ilkka</creatorcontrib><creatorcontrib>Tomson, Charlie R.V.</creatorcontrib><creatorcontrib>Toto, Robert D.</creatorcontrib><creatorcontrib>Tsukamoto, Yusuke</creatorcontrib><creatorcontrib>Tuttle, Katherine R.</creatorcontrib><creatorcontrib>Wada, Takashi</creatorcontrib><creatorcontrib>Williams, Winfred W.</creatorcontrib><creatorcontrib>Zhang, Hong</creatorcontrib><creatorcontrib>Zoungas, Sophia</creatorcontrib><creatorcontrib>Conference Participants</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Kidney international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Perkovic, Vlado</au><au>Agarwal, Rajiv</au><au>Fioretto, Paola</au><au>Hemmelgarn, Brenda R.</au><au>Levin, Adeera</au><au>Thomas, Merlin C.</au><au>Wanner, Christoph</au><au>Kasiske, Bertram L.</au><au>Wheeler, David C.</au><au>Groop, Per-Henrik</au><au>Bakris, George L.</au><au>Cooper, Mark E.</au><au>Chae, Dong-Wan</au><au>Davidson, Michael H.</au><au>de Boer, Ian H.</au><au>de Zeeuw, Dick</au><au>Fornoni, Alessia</au><au>Gnudi, Luigi</au><au>Herzog, Charles A.</au><au>Hung, Adriana M.</au><au>Jafar, Tazeen Hasan</au><au>Jardine, Meg</au><au>Jha, Vivekanand</au><au>Ji, Linong</au><au>Kahn, Steven E.</au><au>Langham, Robyn G.</au><au>Lerma, Edgar V.</au><au>Ma, Ronald C.W.</au><au>Makino, Hirofumi</au><au>Marre, Michel</au><au>Mauer, Michael</au><au>Metsärinne, Kaj</au><au>Nelson, Robert G.</au><au>Pecoits-Filho, Roberto</au><au>Pollock, Carol A.</au><au>Rajapurkar, Mohan</au><au>Rossing, Peter</au><au>Rychlík, Ivan</au><au>Sharma, Kumar</au><au>Stanton, Robert C.</au><au>Tesař, Vladimír</au><au>Tikkanen, Ilkka</au><au>Tomson, Charlie R.V.</au><au>Toto, Robert D.</au><au>Tsukamoto, Yusuke</au><au>Tuttle, Katherine R.</au><au>Wada, Takashi</au><au>Williams, Winfred W.</au><au>Zhang, Hong</au><au>Zoungas, Sophia</au><aucorp>Conference Participants</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference</atitle><jtitle>Kidney international</jtitle><addtitle>Kidney Int</addtitle><date>2016-12</date><risdate>2016</risdate><volume>90</volume><issue>6</issue><spage>1175</spage><epage>1183</epage><pages>1175-1183</pages><issn>0085-2538</issn><eissn>1523-1755</eissn><abstract>The prevalence of diabetes around the world has reached epidemic proportions and is projected to increase to 642 million people by 2040. Diabetes is already the leading cause of end-stage kidney disease (ESKD) in most developed countries, and the growth in the number of people with ESKD around the world parallels the increase in diabetes. The presence of kidney disease is associated with a markedly elevated risk of cardiovascular disease and death in people with diabetes. Several new therapies and novel investigational agents targeting chronic kidney disease patients with diabetes are now under development. This conference was convened to assess our current state of knowledge regarding optimal glycemic control, current antidiabetic agents and their safety, and new therapies being developed to improve kidney function and cardiovascular outcomes for this vulnerable population.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27884312</pmid><doi>10.1016/j.kint.2016.09.010</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0085-2538 |
| ispartof | Kidney international, 2016-12, Vol.90 (6), p.1175-1183 |
| issn | 0085-2538 1523-1755 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1844025881 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | antidiabetic agents cardiovascular disease chronic kidney disease diabetes Diabetic Nephropathies - therapy glycemic control Humans Renal Insufficiency, Chronic - therapy renoprotection |
| title | Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T06%3A03%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20patients%20with%20diabetes%20and%20CKD:%C2%A0conclusions%20from%20a%20%E2%80%9CKidney%20Disease:%20Improving%20Global%20Outcomes%E2%80%9D%20(KDIGO)%20Controversies%20Conference&rft.jtitle=Kidney%20international&rft.au=Perkovic,%20Vlado&rft.aucorp=Conference%20Participants&rft.date=2016-12&rft.volume=90&rft.issue=6&rft.spage=1175&rft.epage=1183&rft.pages=1175-1183&rft.issn=0085-2538&rft.eissn=1523-1755&rft_id=info:doi/10.1016/j.kint.2016.09.010&rft_dat=%3Cproquest_cross%3E1844025881%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1844025881&rft_id=info:pmid/27884312&rft_els_id=S0085253816305154&rfr_iscdi=true |